Business
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
-- Zola® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia’s history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026. “We are very pleased with our performance during the first quarter of 2026,” said T.J. Schaefer, CEO of Arcadia. “We were able to bring in gross proceeds of approximately $2.1 millio
About this update from Arcadia Biosciences, Inc.
[{"type":"image","alt":"Arcadia Biosciences, Inc.","displaySize":"","headline":null,"caption":"Arcadia Biosciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":211,"url":"https://media.zenfs.com/en/globenewswire.com/15eb3ad0266744fc0169ab2baa2c150a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/cd4unGURAZ9Y.aSkIhjWjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI5NQ--/https://media.zenfs.com/en/globenewswire.com/15eb3ad0266744fc0169ab2baa2c150a","width":300,"height":211},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/cd4unGURAZ9Y.aSkIhjWjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI5NQ--/https://media.zenfs.com/en/globenewswire.com/15eb3ad0266744fc0169ab2baa2c150a","width":300,"height":211}},"lazy":false},{"type":"text","content":" -- Zola® volumes increase 18% year-over-year --","length":47,"tagName":"p"},{"type":"text","content":"-- SG&A at lowest level in Arcadia’s history --","length":51,"tagName":"p"},{"type":"text","content":"DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026.","length":221,"tagName":"p"},{"type":"text","content":"“We are very pleased with our performance during the first quarter of 2026,” said T.J. Schaefer, CEO of Arcadia. “We were able to bring in gross proceeds of approximately $2.1 million from the exercise of previously outstanding preferred investment options, Zola® coconut water revenues and volumes increased at a double-digit rate compared to the same quarter last year, and our selling, general, and administrative expenses are at the lowest level in Arcadia’s history as a public company.","length":491,"tagName":"p"},{"type":"text","content":"“Going forward, we continue to evaluate strategic alternatives but also remain focused on growing our Zola coconut water brand and are excited about the prospects of launching a new product that we expect to be on the shelves of many of our largest customers this fall,” Schaefer added.","length":286,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"9","style":"text-align:center;vertical-align:middle;text-align:center;vertical-align:middle;vertical-align:bottom;","val":[{"type":"text","content":"Arcadia Biosciences, Inc. Financial Snapshot(U...